期刊文献+

氢溴酸右美沙芬热敏型鼻用凝胶的制备及体外释放 被引量:6

Preparation of the dextromethorphan hydrobromide thermosensitive nasal gel and study on the drug release in vitro
下载PDF
导出
摘要 目的制备氢溴酸右美沙芬热敏型鼻用凝胶,并对其体外释放行为进行考察。方法以热敏型材料泊洛沙姆407为主要辅料制备氢溴酸右美沙芬滴鼻液,采用立式扩散池对该制剂的体外释放行为进行研究。结果该制剂中含泊洛沙姆407质量分数为20%、PEG6000质量分数为2.5%时,室温下为液态,加热至33℃转变为半固状凝胶;药物从凝胶中的释放符合Higuchi方程(r>0.99)。结论该制剂制备简单,与一般鼻用制剂相比具有延长药物在鼻腔内的滞留时间、减少药液流失和避免对咽部的刺激等优点,具有开发前景。 Objective To prepare the dextromethorphan hydrobromide(DMH) thermosensitive gel for nasal drug delivery,and study the drug release in vitro.Methods Themosensitive material Poloxamer407 was used as the main excipient to prepare the nasal drop and a vertical diffusion cell was adopted to study the drug release.Result The solution containing 20%(w) poloxamer407 and 2.5%(w) PEG6000 is liquid state at room temperature,then undergoes a phase transition to a semisolid gel when being heated up to 33 ℃;drug release from poloxamer vehicle followed the Higuchi equation kinetics(r>0.99).Conclusion The preparation,with the unique advantages comparing to traditional nasal preparations,is simple to produce and shows great prospect.
出处 《中国药剂学杂志(网络版)》 2005年第4期205-209,共5页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 热敏凝胶 立式扩散池 氢溴酸右美沙芬 鼻腔给药 体外释放 pharmaceutics thermosensitive gel Franz diffusion cell dextromethorphan hydrobromide nasal administration drug release in vitro
  • 相关文献

参考文献11

二级参考文献62

  • 1陈庆华.现代微丸制备与包衣装置的类型与应用[J].中国医药工业杂志,1996,27(3):134-139. 被引量:25
  • 2何绍雄.时间药理学与时间治疗学[M].天津:科学技术出版社,1974.166-167.
  • 3陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,2000.382.
  • 4.中国药典1995年版二部[S].,1995.附录XC 66-67.
  • 5何绍雄.时间药理学[M].天津:天津科学技术出版社,1994.237.
  • 6Cohen S, Lobel E, Trevgoda A, et al. A novel in situ-forming ophthalmic drug delivery systems from alginates undergoing gelation in the eye [J] .J Controlled Release, 1997,44(2-3) :201.
  • 7Gurny R, Boye T, lbrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery [J ]. J Controlled Release, 1985,2(3 ): 353.
  • 8Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system [ J ]. J Controlled Release ,2001,73(2) :205.
  • 9Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery [J ]. J Controlled Release ,2000,69(3 ) :379.
  • 10Yun MO,Choi HG,Jung JH,et al. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement [J]. Int J Pharm, 1999,189(2) : 137.

共引文献231

同被引文献78

引证文献6

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部